Antipsychotic drugs are overused in Australia as a first-line response to managing behavioral and psychological symptoms experienced by people with dementia, particularly in residential aged care,” said Glenn Rees, Alzheimer’s Australia chief executive, in response to a report on ABC Lateline last week.
There are almost 280,000 Australians currently living with dementia, says the dementia charity. Without a significant medical breakthrough, that is expected to soar to almost 1 million by 2050.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze